Literature DB >> 11711534

'Srcasm: a novel Src activating and signaling molecule.

John T Seykora1, Lijuan Mei, G Paolo Dotto, Paul L Stein.   

Abstract

The Src family tyrosine kinase, Fyn, can facilitate regulation of cell proliferation and differentiation. Mice with mutations in the fyn gene have defects in the brain, immune system, and epidermal differentiation. To identify molecules that may interact with Fyn in the epidermis, we performed a yeast two-hybrid interaction screen of a murine keratinocyte library. A novel adaptor-like molecule was isolated and termed Srcasm for Src activating and signaling molecule. Murine Srcasm is a 52.7-kDa protein that contains a VHS membrane association domain and a number of tyrosine motifs suggesting that it may be a substrate for Src family kinases and serve as an adaptor protein. Northern blot analysis of murine tissues demonstrates that Srcasm expression is highest in brain and kidney. In situ hybridization analysis reveals that srcasm mRNA is expressed in regions of the epidermis and hair follicle where keratinocyte differentiation occurs. In the brain, srcasm mRNA distribution correlates with that of fyn, with both being highly expressed in the hippocampal and cerebellar Purkinje neurons. Fyn can phosphorylate Srcasm, and association of these molecules relies on cooperative binding between the SH2 and SH3 domains of Fyn and corresponding canonical binding sites in Srcasm. Srcasm is capable of interacting with Grb2 and the regulatory subunit of phosphoinositide 3-kinase, p85, in a phosphorylation-dependent manner. The evidence suggests that Srcasm may help promote Src family kinase signaling in cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711534     DOI: 10.1074/jbc.M106813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Structure of the GAT domain of human GGA1: a syntaxin amino-terminal domain fold in an endosomal trafficking adaptor.

Authors:  Silke Suer; Saurav Misra; Layla F Saidi; James H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-31       Impact factor: 11.205

2.  The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.

Authors:  Mélanie Franco; Olivia Furstoss; Valérie Simon; Chrsitine Benistant; Wan Jing Hong; Serge Roche
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.

Authors:  Elias E Ayli; Weijie Li; Tamu T Brown; Agnieszka Witkiewicz; Rosalie Elenitsas; John T Seykora
Journal:  J Cutan Pathol       Date:  2008-03       Impact factor: 1.587

4.  Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Joel Gelfand; John T Seykora
Journal:  J Biol Chem       Date:  2006-10-16       Impact factor: 5.157

5.  Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts.

Authors:  Audrey Sirvent; Oana Vigy; Beatrice Orsetti; Serge Urbach; Serge Roche
Journal:  Mol Cell Proteomics       Date:  2012-09-29       Impact factor: 5.911

6.  Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.

Authors:  Jonathan R St-Germain; Paul Taylor; Jiefei Tong; Lily L Jin; Ana Nikolic; Ian I Stewart; Robert M Ewing; Moyez Dharsee; Zhihua Li; Suzanne Trudel; Michael F Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

7.  Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.

Authors:  Santhosh Girirajan; Paula M Hauck; Stephen Williams; Christopher N Vlangos; Barbara B Szomju; Sara Solaymani-Kohal; Philip D Mosier; Kimber L White; Kathleen McCoy; Sarah H Elsea
Journal:  Mamm Genome       Date:  2008-03-15       Impact factor: 2.957

8.  TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.

Authors:  Ahmed Elmarghani; Hanan Abuabaid; Peter Kjellen
Journal:  Mediators Inflamm       Date:  2010-02-21       Impact factor: 4.711

9.  Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Authors:  Liang Zhao; Weijie Li; Christine Marshall; Thomas Griffin; Matthew Hanson; Ryan Hick; Tzvete Dentchev; Erik Williams; Adrienne Werth; Christopher Miller; Hasan Bashir; Warren Pear; John T Seykora
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

10.  Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor.

Authors:  Ning Sheng Liu; Li Shen Loo; Eva Loh; Li-Fong Seet; Wanjin Hong
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.